CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.88
+0.10 (1.47%)
At close: Jan 20, 2026, 4:00 PM EST
6.87
-0.01 (-0.15%)
After-hours: Jan 20, 2026, 5:00 PM EST
CorMedix Market Cap
CorMedix has a market cap or net worth of $542.07 million as of January 20, 2026. Its market cap has increased by 10.29% in one year.
Market Cap
542.07M
Enterprise Value
635.27M
1-Year Change
10.29%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $542.07M, an increase of 1,485.00%. That is a compound annual growth rate of 19.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 534.20M | -41.70% |
| Dec 31, 2025 | 916.30M | 86.43% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
| May 13, 2010 | 34.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |